Press Releases

2013

SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTSFor the First Three Months of the Fiscal Year, Ending June 30 2014(From July 1, 2013 to September 30, 2013)

(135.6 KB)2013:12:04:10:11:38

PSS and Roche enter into a new Development Agreement concerning emPCR Automation Instrument to be developed by PSS

2013:09:24:16:14:34

SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS For Fiscal Year 2013 (From July 1, 2012 to June 30, 2013)

(145.5 KB)2013:09:03:15:09:28

PSS and LG Life Sciences enter into a Supply and Distribution Agreement for PSS's "geneLEAD", a fully automated, sample-to-result system for NAT

2013:08:08:16:08:19

PSS reaches Desalter Development Agreement with Abbott

2013:06:24:13:34:29

PSS FY 2013 Third Quarter Financial Statements (Summary)

(137.5 KB)2013:05:29:11:10:31

Termination of Agreement with Roche to develop a Fully Automated Emulsion PCR Instrument for Next-generation Sequencing Platforms

2013:05:09:15:09:34

PSS and ELITech Group enter into a Joint Development, Distribution and Supply Agreement on PSS's "geneLEAD", a fully automated, sample-to-result, Real-Time PCR analyzer

2013:04:12:14:43:58

PSS FY 2013 Second Quarter Financial Statements (Summary)

(148.6 KB)2013:02:26:16:31:43
Press Releases
Back to top of page